Literature DB >> 2726755

Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.

E F Terwilliger1, B Godin, J G Sodroski, W A Haseltine.   

Abstract

The construction and properties of an infectious human immunodeficiency virus (HIV) that expresses the bacterial gene chloramphenicol acetyltransferase are described. This virus can be used in vitro to screen for drugs that inhibit HIV infection. The marked virus may also be used to trace the routes of infection from the site of inoculation in animal experiments.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2726755      PMCID： PMC287240          DOI： 10.1073/pnas.86.10.3857

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  29 in total

1.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

2.  Negative regulation of viral enhancers in undifferentiated embryonic stem cells.

Authors:  C M Gorman; P W Rigby; D P Lane
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

3.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

Authors:  J Sodroski; R Patarca; C Rosen; F Wong-Staal; W Haseltine
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

Review 4.  A pathogenic retrovirus (HTLV-III) linked to AIDS.

Authors:  S Broder; R C Gallo
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

5.  Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertional mutagenesis: positions of viable insertion mutations.

Authors:  L I Lobel; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Development and early natural history of HTLV-III antibodies in persons with hemophilia.

Authors:  M E Eyster; J J Goedert; M G Sarngadharan; S H Weiss; R C Gallo; W A Blattner
Journal:  JAMA       Date:  1985-04-19       Impact factor: 56.272

7.  Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection.

Authors:  T H Lee; J E Coligan; T Homma; M F McLane; N Tachibana; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.

Authors:  J J Goedert; M G Sarngadharan; R J Biggar; S H Weiss; D M Winn; R J Grossman; M H Greene; A J Bodner; D L Mann; D M Strong
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

9.  A molecular clone of HTLV-III with biological activity.

Authors:  A G Fisher; E Collalti; L Ratner; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

10.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728
View more
  29 in total

1.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.

Authors:  D H Gabuzda; K Lawrence; E Langhoff; E Terwilliger; T Dorfman; W A Haseltine; J Sodroski
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus.

Authors:  R E Means; T Greenough; R C Desrosiers
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.

Authors:  R Lodge; J P Lalonde; G Lemay; E A Cohen
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.

Authors:  E Helseth; M Kowalski; D Gabuzda; U Olshevsky; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein.

Authors:  R Lodge; L Delamarre; J P Lalonde; J Alvarado; D A Sanders; M C Dokhélar; E A Cohen; G Lemay
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  D H Gabuzda; A Lever; E Terwilliger; J Sodroski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery.

Authors:  Mahdieh Soezi; Arash Memarnejadian; Saeed Aminzadeh; Rezvan Zabihollahi; Seyed Mehdi Sadat; Safieh Amini; Soheila Hekmat; Mohammad Reza Aghasadeghi
Journal:  Rep Biochem Mol Biol       Date:  2015-10

9.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1.

Authors:  L Bergeron; J Sodroski
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.